Aojing Medical (688613.SH): Artificial bone repair materials obtained registration certificate in Thailand

Zhitong Finance App News, Aojing Medical (688613.SH) issued an announcement. The company submitted the registration application data for the company's artificial bone repair materials to the Thai Food and Drug Administration (TFDA) in May 2026. The company recently received a notice from the Food and Drug Administration of Thailand, and the company's artificial bone repair materials were approved.

^{According to reports, the SkuHeal™ artificial bone repair material, which has obtained a Thai registration certificate this time, is a bionic mineralized collagen artificial bone repair material developed and produced based on the company's in vitro bionic mineralization technology with completely independent intellectual property rights. It is highly bionic in terms of composition and microstructure.} The product is used for neurosurgery-related bone defect repair without bone grafting contraindications. After implantation, it can guide bone regeneration and be replaced by new bone tissue crawling. It is an implantable medical device product with good bone tissue regeneration and repair ability, and has broad clinical application potential and market space for various types of clinical bone defect repair.